Besides NSCLC, inflammatory myofibroblastic tumor (~50% have ALK fusions/rearrangements) and anaplastic large cell lymphoma (~50–80% having ALK fusions/rearrangements) are the neoplasms most frequently bearing ALK fusions. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.